产品简要
公司名称 :
Biosensis
产品类型 :
抗体
产品名称 :
小鼠单克隆抗体胶质纤维酸性蛋白[5C10](GFAP): IgG
目录 :
M-1375-100
规格 :
100微升
价格 :
297美元
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
nonconjugated
反应物种 :
人类, 小鼠, 大鼠, 牛
应用 :
免疫印迹, 免疫细胞化学
更多信息或购买 :
Biosensis 产品网页
产品信息
目录代码 :
M-1375-100
产品名称 :
小鼠单克隆抗体胶质纤维酸性蛋白[5C10](GFAP): IgG
宿主物种 :
小鼠
克隆性 :
单克隆
产品类型 :
纯化
规格 :
100微升
标价 :
297美元
克隆 :
5C10
抗体亚型 :
IgG1
产品描述 :
GFAP is a 50 kDa intra-cytoplasmic filamentous protein of the cytoskeleton in astrocytes. During the development of the central nervous system, it is a cell-specific marker that distinguishes astrocytes from other glial cells. GFAP immunoreactivity has been shown in immature oligodendrocytes, epiglottic cartilage, pituicytes, papillary meningiomas, myoepithelial cells of the breast and in non-CNS: Schwann cells, salivary gland neoplasms, enteric glia cells, and metastasizing renal carcinomas.
交叉活性 :
Human, Rat, Mouse, Bovine, Porcine. Predicted to react with other mammalian and avian species.
别名 :
星形胶质细胞;胶质纤维酸性蛋白;GFAP;
免疫原 :
纯化GFAP来自猪脊髓
特异性 :
The specificity of this antibody has been confirmed by WB.
包装 :
Small box at room temperature
应用摘要 :
Western Blotting (WB) and Immunocytochemistry (IC). A dilution of 1:5,000 is recommended for WB. Human GFAP has a predicted length of 432 residues and a MW of 50 kDa. A dilution of 1:500 is recommended for IC. This antibody works well on frozen sections, cells in tissue culture and on formalin fixed histological sections. Biosensis recommends optimal dilutions/concentrations should be determined by the end user.
储存 :
After reconstitution of lyophilised antibody, aliquot and store at -20°C for a higher stability. Avoid freeze-thaw cycles.
产品编号 :
1007
更多信息或购买 :
Biosensis 产品网页
公司信息
Biosensis
39 Winwood Street, Thebarton, South Australia, 5031
info@biosensis.com
www.biosensis.com
61 8 83527711
公司总部: 澳大利亚
Biosensis specializes in antibodies, proteins, ELISA kits and Staining kits for Neuroscience, with particular emphasis on neurotrophins and neurotrophin receptors for which Biosensis has been the worldwide leader and OEM supplier for nearly 30 years. In addition to neurotrophins, our neuroscience portfolio includes products for research in neurodegenerative diseases, neurodevelopment, and neuro-metabolism. Areas of focus include Alzheimer's, Parkinson's and ALS diseases, as well as autophagy and metabolic and stress disorders including metabolic syndrome research, obesity, and neuroimmunology and inflammation.